author-photo

Thomas Pertel

University of Geneva

55

Papers

3742

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Investigation of Allocar TTM Targeting CD70 As a Potential Therapy for an Array of Hematological Malignancies

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (45)
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies

2018 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (17)
Abstract 3751: Allogeneic EGFRvIII chimeric antigen receptor T cells for treatment of glioblastoma

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

2016 Nature
Show All
- Source
- Cite
- Save
Citations (24)
ICOS promotes the function of CD4+ effector T cells during anti-OX40 mediated tumor rejection

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (41)
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

2015 Journal of Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (20)
Corrigendum: An IL-27/NFIL3 signalling axis drives Tim-3 and IL–10 expression and T-cell dysfunction

2015 Nature Communications
Show All
- Source
- Cite
- Save
Citations (8)
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction

2015 Nature Communications
Show All
- Source
- Cite
- Save
Citations (119)